Pluri Inc. Logo

Pluri Inc.

PLUR | TA

Overview

Corporate Details

ISIN(s):
US72942G2030
LEI:
Country:
Israel
Address:
Park Building No. 5, 3508409 Haifa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pluri Inc., formerly Pluristem Therapeutics, is a biotechnology company that researches, develops, and manufactures cell-based products and therapeutics. The company specializes in its proprietary 3D cell-expansion technology platform, which is used to create solutions for commercial use aimed at improving human well-being and sustainability. Pluri develops products from placenta-based cells for applications across the medical and pharmaceutical industries, often in collaboration with research partners and academic institutions.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Pluri Inc.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-03 22:43
Post-Annual General Meeting Information
Immediate Report
Hebrew (modern) 224.6 KB
2025-07-03 22:43
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-07-02 01:15
Director's Dealing
Other Report or Announcement
English 267.8 KB
2025-07-02 01:15
Foreign Filer Report
Other Report or Announcement
English 36.4 KB
2025-05-28 21:57
Proxy Solicitation & Information Statement
mediate Report of Meeting to be held on June 30, 2025
English 1.4 MB
2025-05-28 21:57
Pre-Annual General Meeting Information
mediate Report of Meeting to be held on June 30, 2025
English 184.6 KB
2025-05-28 01:52
Annual Report
Materials for Annual Meeting - Annual Report for 30.06.2024
English 346.4 KB
2025-05-28 01:52
Foreign Filer Report
Materials for Annual Meeting - Annual Report for 30.06.2024
English 36.3 KB
2025-05-28 01:36
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on June 30, 2025, proxy
English 1.4 MB
2025-05-28 01:36
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on June 30, 2025, proxy
English 161.1 KB
2025-05-27 17:56
Pre-Annual General Meeting Information
FORM 8K – Updated Regurding Annual Meeting Date
English 112.3 KB
2025-05-27 17:56
Foreign Filer Report
FORM 8K – Updated Regurding Annual Meeting Date
English 36.3 KB
2025-05-20 17:26
Major Shareholding Notification
Form 13D/A-Yaky Yanay
English 168.9 KB
2025-05-20 17:26
Foreign Filer Report
Form 13D/A-Yaky Yanay
English 36.2 KB
2025-05-15 16:02
Management Discussion and Analysis
Pluri CEO Issues Shareholder Letter
English 110.5 KB

Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pluri Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Ipsen Logo
Develops transformative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN
IVF HARTMANN Holding AG Logo
Produces and distributes medical supplies, wound care, and hygiene items for global healthcare.
Switzerland VBSN
Japan 4552
kainos loboratories,inc Logo Japan 4556
KAKEN PHARMACEUTIAL CO., LTD. Logo Japan 4521
Kamada Ltd. Logo
Develops specialty plasma-derived therapeutics for rare and serious conditions.
Israel KMDA
KANABO GROUP PLC Logo
Develops medical & wellness cannabis products, including a certified metered-dose vaporizer.
United Kingdom KNB
Karo Pharma AB Logo
Sells branded OTC & prescription products for everyday health in over 90 countries.
Sweden KARO
Kidswell Bio Corporation Logo Japan 4584
Kinarus Therapeutics Holding AG Logo
Specialty pharma developing drugs for rare diseases & distributing medicines in Switzerland.
Switzerland KNRS